Physician profile
Weishali V Joshi
NPI 1225036494
$902.22
in general payments reported to CMS, 2019-2025
8 companies · $21.43 in 2025
The $21.43 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $102 · 2021: $25.52 · 2023: $93.53 · 2024: $318 · 2025: $21.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.94 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $320.07 | 2019-2023 | Prolia |
| Abbvie INC. | $200.92 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $123.40 | 2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.12 | 2019 | |
| Janssen Biotech, INC. | $77.99 | 2024 | Tremfya |
| Pfizer INC. | $33.47 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $31.77 | 2019 | |
| Ge Healthcare | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weishali Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.